Xelpmoc Design and Tech Ltd
NSE:XELPMOC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
81
148.32
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Xelpmoc Design and Tech Ltd
Xelpmoc Design & Tech Ltd. provides professional and technical consulting services. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2019-02-04. The Company’s service offerings include technology services and solutions to public and private sector clients, which are engaged in e-commerce, hospitality, healthcare, education, and various other industries. The firm also provides a range of services, including mobile and Web application development, prototype development, thematic product development and data analytics assistance. The firm's products include X-Pand, X-Tact and Claire.ai.
Xelpmoc Design & Tech Ltd. provides professional and technical consulting services. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2019-02-04. The Company’s service offerings include technology services and solutions to public and private sector clients, which are engaged in e-commerce, hospitality, healthcare, education, and various other industries. The firm also provides a range of services, including mobile and Web application development, prototype development, thematic product development and data analytics assistance. The firm's products include X-Pand, X-Tact and Claire.ai.
Revenue Drop: Q2 FY '26 operating revenue fell sharply to INR 7.6 million from INR 16.3 million in Q2 FY '25, but was stable quarter-on-quarter.
Shift to Corporate Focus: Management highlighted a deliberate shift from start-up clients to focusing on corporate segment and in-house product development, expecting traction in coming quarters.
EBITDA & Losses: Q2 EBITDA loss widened to INR 16.1 million (vs. loss of INR 10.2 million YoY), with net loss at INR 19.3 million, partly due to ESOP expenses.
Portfolio Valuation: Fair value of portfolio companies rose to INR 703.4 million as of September 2025, up from INR 572.7 million a year ago.
Product Pipeline: Key products like RELY (Agetech) and DocuXray (legal/fintech automation) are in pilot or early commercial phases; monetization expected from Q3/Q4.
Profitability Goal: Management reiterated focus on reaching EBITDA profitability within the next 1–2 quarters.
Start-up Ecosystem: Funding headwinds persist for new start-ups, but some portfolio companies—Mihup, Woovly, Pencil, TSM—are performing well.
Market Outlook: Management sees improving client interest and expects revenue growth as pilots convert and the environment for start-ups stabilizes.